• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Liposomal cyclosporin A
Date Designated:  04/30/1998
Orphan Designation:  Prevention of fetal and neonatal alloimmune thrombocytopenia
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Vernon Knight, M.D.
Baylor College of Medicine, Dept. of Molecular Phy
One Baylor Plaza
Houston, Texas 77030
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.